James Chavez
Ph.D. Student in Cancer Biology, admitted Autumn 2022
All Publications
-
Human HSPCs CRISPR-engineered to endogenously express oncogenic NRAS generate a transplantable lethal myeloid malignancy targetable with novel RAS therapeutics
ELSEVIER. 2025: 5004-5005
View details for DOI 10.1182/blood-2025-5004
View details for Web of Science ID 001665147100004
-
Inhibition of DOCK1 prevents the clonal expansion of high-risk TP53-mutant clonal hematopoiesis induced by genotoxic stressors
ELSEVIER. 2025: 631-632
View details for DOI 10.1182/blood-2025-631
View details for Web of Science ID 001659024800032
-
Title: In Vivo Clonal Tracing of Hematopoietic Stem and Progenitor Cells Reveals Increased Clonal Heterogeneity during Aging, Alongside Critical Changes in Selection Patterns
ELSEVIER. 2024: 2671-2672
View details for DOI 10.1182/blood-2024-202289
View details for Web of Science ID 001411079100010
-
ENGINEERING SEQUENTIAL MUTATIONS INTO HUMAN HSPCS YIELDS AN AGGRESSIVE MYELOID MALIGNANCY ALLOWING FOR INTERROGATION OF PRELEUKEMIC TRANSFORMATION
ELSEVIER SCIENCE INC. 2024
View details for Web of Science ID 001343414100102
-
ENGINEERING SEQUENTIAL MUTATIONS INTO HUMAN HSPCS YIELDS AN AGGRESSIVE MYELOID MALIGNANCY ALLOWING FOR INTERROGATION OF PRELEUKEMIC TRANSFORMATION
ELSEVIER SCIENCE INC. 2024
View details for Web of Science ID 001325038400107
-
Engineering Sequential Mutations into Human HSPCs Yields an Aggressive Myeloid Malignancy Allowing for Interrogation of Preleukemic Transformation
AMER SOC HEMATOLOGY. 2023
View details for DOI 10.1182/blood-2023-187422
View details for Web of Science ID 001159306703222